IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31

INNOSPEC INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$97.99+1.18 (+1.22%)

Close on Oct 19, 2026

Market cap: $2.42B
P/E (TTM): 21.0
Dividend yield: 1.75%

Fundamental chart

Pick a measure to chart its full history

$1.78BFY2025, +6.1% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Innospec's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jul 23, 2007
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IOSP.

Revenue growth2.9% · median 0.6%

Gross margin27.5% · median 36.3%

Operating margin7.0% · median -0.5%

Company	Revenue	Growth
HUN	$5.90B	+0.6%
CC	$5.80B	-0.9%
IOSP	$1.84B	+2.9%
NGVT	$1.16B	-1.4%
BCPC	$1.09B	+10.1%
PRM	$757.07M	+24.2%

Company

Next earnings (est.): Nov 4, 2026, before open
Exchange: Nasdaq
Industry: Chemicals & Allied Products
Fiscal year ends: December 31
Employees: 2,450
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1054905

Advertisement
300 × 250